Skip to main content
Year archive

BioSenic SA — 2018 filings

All 82 regulatory filings released by BioSenic SA (BIOS) in 2018, sourced directly from the official regulator.

82 Filings
2018 Period
2018 filings (82)
Filing Released Lang
PR_2018-12-24_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2018-12-24 English
PR_2018-12-24_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-12-24 French
PR_2018-12-11_BT_Transparency Notification SRIW_EN_Final.pdf
Major Shareholding Notification
2018-12-11 English
PR_2018-12-11_BT_Transparency Notification SRIW_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-12-11 French
PR_2018-11-29_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2018-11-29 English
PR_2018-11-29_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-11-29 French
PR_2018-11-07_BT_2018-Q3_EN_Final.pdf
Interim / Quarterly Report 9M 2018
2018-11-07 English
PR_2018-11-07_BT_2018-Q3_FR_Final.pdf
Interim / Quarterly Report 9M 2018
2018-11-07 French
Bone Therapeutics announces conclusions from interim analysis of Phase III PREOB study in hip osteonecrosis
Regulatory Filings
2018-11-06 English
Bone Therapeutics annonce les conclusions de l'analyse intermédiaire de l'étude de phase III avec PREOB dans l’ostéonécrose de la hanche
Regulatory Filings
2018-11-06 French
PR_2018-10-25_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2018-10-25 English
PR_2018-10-25_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-10-25 French
PR_2018-09-27_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2018-09-27 English
PR_2018-09-27_BT_CB Denominator_FR_Final.pdf
Share Issue/Capital Change
2018-09-27 French
Bone Therapeutics announces final results from Phase I/IIA ALLOB delayed-union fracture study
Legal Proceedings Report
2018-09-14 English
Bone Therapeutics annonce les résultats finaux de l’étude de Phase I/IIA avec ALLOB dans les fractures avec retard de consolidation
Regulatory Filings
2018-09-14 French
PR_2018-09-03_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2018-09-03 English
PR_2018-09-03_BT_CB Denominator_FR_Final.pdf
Share Issue/Capital Change
2018-09-03 French
PR_2018-08-30_BT_2018H1_EN_Final.pdf
Interim / Quarterly Report H1 2018
2018-08-30 English
CP_2018-08-30_BT_2018H1_FR_Final.pdf
Earnings Release H1 2018
2018-08-30 French
20180830_Bone Therapeutics_Interim Financial Report H1 2018_EN_Final.pdf
Interim / Quarterly Report H1 2018
2018-08-30 English
20180830_Bone Therapeutics_Interim Financial Report H1 2018_FR_Final.pdf
Interim / Quarterly Report H1 2018
2018-08-30 French
PR_2018-07-20_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2018-07-20 English
PR_2018-07-20_BT_CB Denominator_FR_Final.pdf
Share Issue/Capital Change
2018-07-20 French
20180711_BOTHE_AGE_PV.pdf
AGM Information
2018-07-16 French
BT_2018-06-27_AGE2_Rapport special Conseil Administration_FR_Addendum_update.pdf
Capital/Financing Update
2018-06-21 French
BT_Special Report from the Board - warrants.pdf
Capital/Financing Update
2018-06-21 French
BT_2018-06-01_AGO-AGE 2018_Plan de warrants_EN_modifie.pdf
Remuneration Information
2018-06-21 English
BT_2018-06-21_AGE_Convocation_FR.pdf
AGM Information
2018-06-21 French
BT_2018-06-21_AGE_Convocation_EN.pdf
Proxy Solicitation & Information Statement
2018-06-21 English
BT_2018-06-21_AGE_Procuration_FR.pdf
Proxy Solicitation & Information Statement
2018-06-21 French
BT_2018-06-21_AGE_Procuration_EN.pdf
Proxy Solicitation & Information Statement
2018-06-21 English
BT_2018-06-01_AGO-AGE 2018_Rapport special Conseil Administration_FR_Addendum.pdf
Capital/Financing Update
2018-06-21 French
BT_2018-06-21_AGE_Droits actionnaires_EN.pdf
AGM Information
2018-06-21 English
BT_2018-06-21_AGE_Droits actionnaires_FR.pdf
AGM Information
2018-06-21 French
PR_2018-06-21_BT_Notice AGE 2018-07-09_EN_Final.pdf
Report Publication Announcement
2018-06-21 English
PR_2018-06-21_BT_Notice AGE 2018-07-09_FR_Final.pdf
AGM Information
2018-06-21 French
20180613_BOTHE_AGE_PV.pdf
AGM Information
2018-06-15 French
20180613_BOTHE_AGO_PV.pdf
AGM Information
2018-06-15 French
PR_2018-06-11_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2018-06-11 English
PR_2018-06-11_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-06-11 French
PR_2018-05-28_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2018-05-28 English
PR_2018-05-28_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-05-28 French
BT_2018-06-01_AGO-AGE 2018_Rapport special Conseil Administration_FR_Addendum.pdf
Capital/Financing Update
2018-05-09 French
BT_2018-05-09_AGO-AGE 2018_Droits actionnaires_EN.pdf
AGM Information
2018-05-09 English
BT_2018-06-01_AGO-AGE 2018_Procuration_FR_modifiee.pdf
AGM Information
2018-05-09 French
BT_2018-05-09_AGO-AGE 2018_Procuration_EN.pdf
Proxy Solicitation & Information Statement
2018-05-09 English
BT_2018-06-01_AGO-AGE 2018_Convocation_FR_modifiee.pdf
AGM Information
2018-05-09 French
BT_Plan de warrants_EN.pdf
Capital/Financing Update
2018-05-09 English
BT_Special Report from the Board - warrants.pdf
Capital/Financing Update
2018-05-09 French
BT_2018-06-01_AGO-AGE 2018_Convocation_EN_modifiee.pdf
AGM Information
2018-05-09 English
BT_2018-05-09_AGO-AGE 2018_Procuration_FR.pdf
AGM Information
2018-05-09 French
BT_2018-06-01_AGO-AGE 2018_Plan de warrants_EN_modifie.pdf
Remuneration Information
2018-05-09 English
BT_2018-05-09_AGO-AGE 2018_Droits actionnaires_FR.pdf
AGM Information
2018-05-09 French
Bone Therapeutics_AR2017_EN_18235-05_MD.pdf
Regulatory Filings
2018-05-09 English
BT_2018-05-09_Bios_EN.pdf
Board/Management Information
2018-05-09 English
Bone Therapeutics_AR2017_FR_18235-04_MD.pdf
Annual Report FY 2017
2018-05-09 French
BT_2018-05-09_Rapport Bone Statutaire.pdf
Audit Report / Information FY 2017
2018-05-09 French
BT_2018-05-09_Comptes annuels 2017_FINAL.pdf
Annual Report FY 2017
2018-05-09 French
BT_2018-05-09_AGO-AGE 2018_Convocation_EN.pdf
AGM Information
2018-05-09 English
BT_2018-05-09_AGO-AGE 2018_Convocation_FR.pdf
AGM Information
2018-05-09 French
PR_2018-05-04_BT_2017-Q1_EN_Final.pdf
Earnings Release Q1 2018
2018-05-04 English
PR_2018-05-04_BT_2017-Q1_FR_Final.pdf
Earnings Release Q1 2018
2018-05-04 French
PR_2018-05-04_BT_CB Denominator_EN_Final.pdf
Share Issue/Capital Change
2018-05-04 English
PR_2018-05-04_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-05-04 French
Bone Therapeutics_AR2017_EN_18235-05_MD.pdf
Annual Report FY 2017
2018-04-25 English
Bone Therapeutics_AR2017_FR_18235-04_MD.pdf
Annual Report FY 2017
2018-04-25 French
PR_2018-04-25_BT_FY2017_EN_Long_Final.pdf
Earnings Release FY 2017
2018-04-25 English
PR_2018-04-25_BT_FY2017_FR_Long_Final.pdf
Annual Report FY 2017
2018-04-25 French
PR_2018-04-04_BT_Transparency Notification SRIW_EN_Final.pdf
Major Shareholding Notification
2018-04-04 English
PR_2018-04-04_BT_Transparency Notification SRIW_FR_Final.pdf
Major Shareholding Notification
2018-04-04 French
PR_2018-03-21_BT_CB Denominator_EN_Final.pdf
Major Shareholding Notification
2018-03-21 English
PR_2018-03-21_BT_CB Denominator_FR_Final.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-03-21 French
BT_2018_Rapport CA_Copie conforme.pdf
Regulatory Filings
2018-03-09 French
Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement
Capital/Financing Update
2018-03-07 English
Bone Therapeutics collecte 19,45 M€ d’engagements dans le cadre d’un placement d’obligations convertibles
Capital/Financing Update
2018-03-07 French
Bone Therapeutics Announces Private Placement of Convertible Bonds
Capital/Financing Update
2018-03-07 English
Bone Therapeutics annonce un placement privé sous forme d’obligations convertibles
Capital/Financing Update
2018-03-07 French
Bone Therapeutics strengthens Board with the appointment of Jean Stéphenne as Chairman
Board/Management Information
2018-02-20 English
Bone Therapeutics annonce le renforcement de son Conseil d’administration avec la nomination de Jean Stéphenne en tant que Président
Board/Management Information
2018-02-20 French
Bone Therapeutics provides business outlook and announces its financial calendar for 2018
Regulatory Filings
2018-01-23 English
Bone Therapeutics publie ses perspectives d’affaires et annonce son calendrier financier pour 2018
Earnings Release FY 2017
2018-01-23 French